Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons

Journal of Infectious Diseases

Volumn 175, Issue 5, 1997, Pages 1210-1215

  Clerici, Mario ^a   Piconi, Stefania ^b   Balotta, Claudia ^b   Trabattoni, Daria ^b   Capetti, Amedeo ^b   Fusi, Maria Luisa ^b   Ruzzante, Stefania ^b   Longhi, Renato ^b   Colombo, Maria Chiara ^b   Moroni, Mauro ^b   Milazzo, Francesco ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA FRAGMENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LYMPHOTOXIN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CELL DEATH; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA;

EID: 16944366607     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593570     Document Type: Article

References (15)

1. Strieter RM, Remick DG, Ward PA, et al. Cellular and molecular regulation of tumor necrosis factor α production by pentoxifylline. Biochem Biophys Res Commn 1988;155:1230-6.
2. Zabel P, Wolter DT, Schonharting MM, Schade UF. Oxpentoxifylline in endotoxaemia. Lancet 1989;2:1474-7.
3. Dezube BJ, Pardee AB, Chapman B, et al. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J AIDS 1993;6:787-94.
4. Vaira LL, Capetti A, Grassi MG, Rizzardini G, Cremoni L, Milazzo F. Treatment of HIV infected patients with pentoxifylline. AIDS 1994;8(suppl 4):P34.
5. Biswas DR, Dezube BJ, Ahlers CM, Pardee AB. Pentoxifylline inhibits HIV-1-LTR-driven gene expression by blocking NF-κβ action. J AIDS 1993;6:778-86.
6. Navarro J, Punzon C, Pizarro A, Fernandez-Cruz E, Fresno M, Munoz-Fernandez MA. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumor necrosis factor synthesis or nuclear factor-κ activation. AIDS 1996;10:469-75.
7. Clerici M, Stocks NI, Zajac RA, et al. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989;339:383-5.
8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
9. Zabel P, Schade FV, Schlaak M. Inhibition of endogenous TNF formation by pentoxifilline. Immunobiology 1993;187:447-63.
10. Dezube BJ, Sherman ML, Fridovich Keil JL, Allen-Ryan J, Pardee AB. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol Immunother 1993;36:57-60.
11. Di Perri G, Di Perri IG, Monteiro GB, et al. Pentoxyfilline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995;171:1317-22.
12. + cell numbers and clinical staging. J Clin Invest 1989;84:1892-9.
13. Clerici M, Roilides E, Butler KM, et al. Changes in T helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity. Blood 1992;80:2196-202.
14. Emilie D, Maillot MC, Nicolas JF, Fior R, Galanaud P. Antagonistic effect of IFN gamma on tat-induced transactivation of HIV by long terminal repeat. J Biol Chem 1992;267:20565-70.
15. + T cells. Immunol Today 1996;17:217-24.